BIO's State of VC Investment Trends

David Thomas, BIO’s Vice President of Industry Analysis, will provide an overview of recent investment and deal trends for emerging therapeutic companies followed by a discussion. While venture investment remains strong, learn more about data trends from the past decade and considerations for the future. Visit bio.org/iareports to view the full report.